Aynur Ünalp

6.1k total citations · 2 hit papers
32 papers, 4.6k citations indexed

About

Aynur Ünalp is a scholar working on Epidemiology, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Aynur Ünalp has authored 32 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 9 papers in Surgery and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Aynur Ünalp's work include Liver Disease Diagnosis and Treatment (15 papers), Diet, Metabolism, and Disease (7 papers) and Liver Disease and Transplantation (6 papers). Aynur Ünalp is often cited by papers focused on Liver Disease Diagnosis and Treatment (15 papers), Diet, Metabolism, and Disease (7 papers) and Liver Disease and Transplantation (6 papers). Aynur Ünalp collaborates with scholars based in United States, Türkiye and Belgium. Aynur Ünalp's co-authors include Elizabeth M. Brunt, Joel E. Lavine, David E. Kleiner, Nathan M. Bass, Naga Chalasani, James Tonascia, Brent A. Neuschwander‐Tetri, Kris V. Kowdley, Mark L. Van Natta and Arthur J. McCullough and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Hepatology.

In The Last Decade

Aynur Ünalp

32 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

2010 2.5k citations Arun J. Sanyal, Naga Chalasani et al. New England Journal of Medicine profile →
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis

2012 372 citations Rohit Loomba, M. Roselle Abraham et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aynur Ünalp United States	17	4.1k	2.1k	1.7k	702	673	32	4.6k
Etsuko Hashimoto Japan	35	4.4k 1.1×	1.8k 0.9×	2.3k 1.4×	681 1.0×	771 1.1×	107	5.2k
Shivakumar Chitturi Australia	25	4.4k 1.1×	2.1k 1.0×	1.5k 0.9×	766 1.1×	745 1.1×	40	5.5k
Carol Sargeant United States	12	3.5k 0.9×	1.7k 0.8×	1.5k 0.9×	728 1.0×	851 1.3×	17	4.2k
M. Marietti Italy	8	4.0k 1.0×	1.6k 0.8×	1.5k 0.9×	975 1.4×	595 0.9×	17	4.6k
Romina Lomonaco United States	25	3.6k 0.9×	2.2k 1.1×	1.1k 0.7×	710 1.0×	734 1.1×	37	4.2k
Stefano Ballestri Italy	32	4.5k 1.1×	2.3k 1.1×	1.6k 1.0×	734 1.0×	637 0.9×	54	5.3k
Fabio Nascimbeni Italy	28	4.1k 1.0×	2.2k 1.1×	1.5k 0.9×	594 0.8×	563 0.8×	54	4.8k
Manirath Srishord United States	13	3.6k 0.9×	1.8k 0.8×	1.6k 0.9×	453 0.6×	606 0.9×	28	4.0k
Dawn M. Torres United States	23	3.4k 0.8×	1.5k 0.7×	1.5k 0.9×	456 0.6×	479 0.7×	38	3.8k
Eduardo Vilar‐Gómez United States	26	3.9k 1.0×	1.8k 0.8×	1.9k 1.2×	396 0.6×	647 1.0×	76	4.3k

Countries citing papers authored by Aynur Ünalp

Since Specialization

Citations

This map shows the geographic impact of Aynur Ünalp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aynur Ünalp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aynur Ünalp more than expected).

Fields of papers citing papers by Aynur Ünalp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aynur Ünalp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aynur Ünalp. The network helps show where Aynur Ünalp may publish in the future.

Co-authorship network of co-authors of Aynur Ünalp

This figure shows the co-authorship network connecting the top 25 collaborators of Aynur Ünalp. A scholar is included among the top collaborators of Aynur Ünalp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aynur Ünalp. Aynur Ünalp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pasricha, Pankaj J., Katherine P. Yates, John O. Clarke, et al.. (2014). 792 Mortality and Predictors of Improvement in Patients With Gastroparesis: 4-Year Outcomes From the Gastroparesis Clinical Research Consortium. Gastroenterology. 146(5). S–136. 1 indexed citations

Bambha, Kiran, Laura Wilson, Aynur Ünalp, et al.. (2013). Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis. Liver International. 34(8). 1250–1258. 66 indexed citations

Koch, Kenneth L., William L. Hasler, Katherine P. Yates, et al.. (2013). Tu2092 Contrasting Gastroparesis in Type 1 (T1DM) vs. Type 2 (T2DM) Diabetes: Clinical Course After 48 Weeks of Follow-up and Relation to Comorbidities and Health Resource Utilization. Gastroenterology. 144(5). S–926. 1 indexed citations

Loomba, Rohit, M. Roselle Abraham, Aynur Ünalp, et al.. (2012). Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis. Hepatology. 56(3). 943–951. 372 indexed citations breakdown →

Guy, Cynthia D., Ayako Suzuki, James L. Burchette, et al.. (2011). Costaining for keratins 8/18 plus ubiquitin improves detection of hepatocyte injury in nonalcoholic fatty liver disease. Human Pathology. 43(6). 790–800. 49 indexed citations

Vos, Miriam B., Ryan Colvin, Patricia Belt, et al.. (2011). Correlation of Vitamin E, Uric Acid, and Diet Composition With Histologic Features of Pediatric NAFLD. Journal of Pediatric Gastroenterology and Nutrition. 54(1). 90–96. 95 indexed citations

Guy, Cynthia D., Ayako Suzuki, Marzena Zdanowicz, et al.. (2011). Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease. Hepatology. 55(6). 1711–1721. 168 indexed citations

Zein, Claudia O., et al.. (2010). Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. Journal of Hepatology. 54(4). 753–759. 165 indexed citations

Vuppalanchi, Raj, John D. Olson, Aynur Ünalp, et al.. (2010). Generalizability of the Nonalcoholic Steatohepatitis Clinical Research Network Histologic Scoring System for Nonalcoholic Fatty Liver Disease. Journal of Clinical Gastroenterology. 45(1). 55–58. 107 indexed citations

10.

Sanyal, Arun J., Naga Chalasani, Kris V. Kowdley, et al.. (2010). Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis. New England Journal of Medicine. 362(18). 1675–1685. 2468 indexed citations breakdown →

11.

Ünalp, Aynur, et al.. (2009). Does Poly-N-Acetyl Glucosamine Patch Use Reduce Arteriovenous Fistula and Graft Failure Rates in Hemodialysis Patients With End-Stage Renal Disease?. The American Journal of the Medical Sciences. 338(3). 178–184. 3 indexed citations

12.

David, Kristin, Kris V. Kowdley, Aynur Ünalp, et al.. (2009). Quality of life in adults with nonalcoholic fatty liver disease. Hepatology. 49(6). 1904–1912. 133 indexed citations

13.

Lavine, Joel E., Jeffrey B. Schwimmer, Jean P. Molleston, et al.. (2009). Treatment of nonalcoholic fatty liver disease in children: TONIC trial design. Contemporary Clinical Trials. 31(1). 62–70. 65 indexed citations

14.

Brunt, Elizabeth M., David E. Kleiner, Laura Wilson, et al.. (2008). Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD). Hepatology. 49(3). 809–820. 288 indexed citations

15.

Chalasani, Naga, Laura Wilson, David E. Kleiner, et al.. (2008). Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease. Journal of Hepatology. 48(5). 829–834. 173 indexed citations

16.

Chalasani, Naga P., Arun J. Sanyal, Kris V. Kowdley, et al.. (2008). Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. Contemporary Clinical Trials. 30(1). 88–96. 135 indexed citations

17.

Ünalp, Aynur, et al.. (2006). Presentation in relation to publication of results from clinical trials. Contemporary Clinical Trials. 28(4). 358–369. 6 indexed citations

18.

Heath, E., Marcia Irene Canto, Steven Piantadosi, et al.. (2003). Chemoprevention for Barrett’s Esophagus Trial. Design and outcome measures. Diseases of the Esophagus. 16(3). 177–186. 29 indexed citations

19.

Ünalp, Aynur, et al.. (2000). FDA Censoring of Manufacturersʼ Postmarketing Commitments in HIV/AIDS Drug Approval Letters. American Journal of Therapeutics. 7(4). 257–264. 1 indexed citations

20.

Deǧertekin, Muzaffer, et al.. (1999). Exercise electrocardiography test in patients with aortic stenosis. International Journal of Cardiology. 69(3). 281–287. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact